PMQs Twitter round-up: Cancer targets, PFI and a reluctant foray into the EU

There were several bad-tempered exchanges between David Cameron and Jeremy Corbyn in this week's PMQs but it took the intervention of SNP and Tory backbenchers before the elephant in the room - the new deal with the EU - was discussed.

PMQs Twitter round-up: Cancer targets, PFI and a reluctant foray into the EU

The EU deal, painstakingly negotiated between David Cameron and European member states, was the expected topic of conversation today but the Labour leader took the opportunity of tomorrow's World Cancer Day to attack the Government's record on treating people in the NHS.


But Cameron responded by attacking the Labour-run administration in Wales and demanded that Corbyn pick up the phone to his colleagues and do something about it.



It was not until SNP leader Angus Robertson got to his feet, halfway through PMQs, that the subject everyone was expecting was finally discussed.

But as always with the EU, it takes a Tory backbencher, in this case Christopher Chope, to make the Prime Minister uncomfortable.

Chope accused Cameron of reneging on a manifesto commitment regarding benefits to EU migrants but Cameron politely declined to agree with his backbencher.

Then came an odd own-goal from Labour backbencher Stella Creasy, who used a question to highlight how her NHS trust was spending £1.5m per week in interest payments under Private Finance Initiative deals but Cameron, predictably, shot back that most PFI deals that exist today were signed during the last Labour administration.

The session left some commentators thinking that Labour's lack of policy around the EU had been exposed.

According to Brandwatch, there were 8,600 tweets during the half-hour session with the highest numbers on the subjects of the NHS, the EU and Wales.

Tweets about Cameron were 14.5 per cent positive and 85.5 per cent negative while for Corbyn they were 24.2 per cent positive, 75.8 per cent negative.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in